WADDAH NASSAR: Open Payments
NPI 1144252909 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,448 in 140 payments from 26 companies in 2025. Trend: 2023 $2,068 · 2024 $2,390 · 2025 $2,448
Food & beverage: $2,313Education: $134
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $295 |
| Otsuka America Pharmaceutical, Inc. | 24 | $277 |
| Bayer Healthcare Pharmaceuticals Inc. | 15 | $274 |
| ABBVIE INC. | 16 | $233 |
| PFIZER INC. | 12 | $177 |
| Astellas Pharma US Inc | 6 | $153 |
| Amgen Inc. | 9 | $152 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $146 |
| Mannkind Corporation | 4 | $101 |
| Abbott Laboratories | 5 | $92 |
Products named: REXULTI, Kerendia, AIRSUPRA, UBRELVY, NURTEC ODT, CAPLYTA, AFREZZA, OTEZLA.
Industry payments across OK — which companies pay providers there.
